CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in HUMA — Humacyte, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in HUMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,055,741
+$271,895 QoQ
Shares Held
1,353,515
+4.8% QoQ
Ownership
0.487%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 163 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HUMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. HUMA ranks #220 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in HUMA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,055,741 | 1,353,515 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $783,846 | 1,291,345 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,191,137 | 1,239,477 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,760,735 | 1,011,917 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,926,714 | 921,873 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,304,756 | 765,253 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $3,917,375 | 775,718 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,923,969 | 721,318 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,140,985 | 654,372 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,473,415 | 473,767 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,395,169 | 491,257 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,343,296 | 458,463 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,142,692 | 399,543 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,224,730 | 396,353 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $844,388 | 400,184 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $990,140 | 303,724 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,060,924 | 330,506 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,129,592 | 301,642 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,133,240 | 294,240 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||